Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Clever-1 contributes to lymphocyte entry into the spleen via the red pulp.

Tadayon S, Dunkel J, Takeda A, Halle O, Karikoski M, Gerke H, Rantakari P, Virtakoivu R, Pabst O, Salmi M, Hollmén M, Jalkanen S.

Sci Immunol. 2019 Mar 29;4(33). pii: eaat0297. doi: 10.1126/sciimmunol.aat0297.

PMID:
30926591
2.

Enhanced Antibody Production in Clever-1/Stabilin-1-Deficient Mice.

Dunkel J, Viitala M, Karikoski M, Rantakari P, Virtakoivu R, Elima K, Hollmén M, Jalkanen S, Salmi M.

Front Immunol. 2018 Oct 8;9:2257. doi: 10.3389/fimmu.2018.02257. eCollection 2018.

3.

Gene-expression profiling of different arms of lymphatic vasculature identifies candidates for manipulation of cell traffic.

Iftakhar-E-Khuda I, Fair-Mäkelä R, Kukkonen-Macchi A, Elima K, Karikoski M, Rantakari P, Miyasaka M, Salmi M, Jalkanen S.

Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):10643-8. doi: 10.1073/pnas.1602357113. Epub 2016 Sep 6.

4.

Stabilin-1 expression defines a subset of macrophages that mediate tissue homeostasis and prevent fibrosis in chronic liver injury.

Rantakari P, Patten DA, Valtonen J, Karikoski M, Gerke H, Dawes H, Laurila J, Ohlmeier S, Elima K, Hübscher SG, Weston CJ, Jalkanen S, Adams DH, Salmi M, Shetty S.

Proc Natl Acad Sci U S A. 2016 Aug 16;113(33):9298-303. doi: 10.1073/pnas.1604780113. Epub 2016 Jul 29.

5.

Erratum: The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes.

Rantakari P, Auvinen K, Jäppinen N, Kapraali M, Valtonen J, Karikoski M, Gerke H, Iftakhar-E-Khuda I, Keuschnigg J, Umemoto E, Tohya K, Miyasaka M, Elima K, Jalkanen S, Salmi M.

Nat Immunol. 2015 May;16(5):544. doi: 10.1038/ni0515-544c. No abstract available.

PMID:
25898202
6.

The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes.

Rantakari P, Auvinen K, Jäppinen N, Kapraali M, Valtonen J, Karikoski M, Gerke H, Iftakhar-E-Khuda I, Keuschnigg J, Umemoto E, Tohya K, Miyasaka M, Elima K, Jalkanen S, Salmi M.

Nat Immunol. 2015 Apr;16(4):386-96. doi: 10.1038/ni.3101. Epub 2015 Feb 9. Erratum in: Nat Immunol. 2015 May;16(5):544.

PMID:
25665101
7.

Ecto-5'-nucleotidase/CD73 enhances endothelial barrier function and sprouting in blood but not lymphatic vasculature.

Yegutkin GG, Auvinen K, Rantakari P, Hollmén M, Karikoski M, Grénman R, Elima K, Jalkanen S, Salmi M.

Eur J Immunol. 2015 Feb;45(2):562-73. doi: 10.1002/eji.201444856. Epub 2014 Dec 15.

8.

Clever-1/stabilin-1 controls cancer growth and metastasis.

Karikoski M, Marttila-Ichihara F, Elima K, Rantakari P, Hollmén M, Kelkka T, Gerke H, Huovinen V, Irjala H, Holmdahl R, Salmi M, Jalkanen S.

Clin Cancer Res. 2014 Dec 15;20(24):6452-64. doi: 10.1158/1078-0432.CCR-14-1236. Epub 2014 Oct 15.

9.

Consequences of the lack of CD73 and prostatic acid phosphatase in the lymphoid organs.

Yegutkin GG, Auvinen K, Karikoski M, Rantakari P, Gerke H, Elima K, Maksimow M, Quintero IB, Vihko P, Salmi M, Jalkanen S.

Mediators Inflamm. 2014;2014:485743. doi: 10.1155/2014/485743. Epub 2014 Aug 24.

10.

SHARPIN regulates uropod detachment in migrating lymphocytes.

Pouwels J, De Franceschi N, Rantakari P, Auvinen K, Karikoski M, Mattila E, Potter C, Sundberg JP, Hogg N, Gahmberg CG, Salmi M, Ivaska J.

Cell Rep. 2013 Nov 14;5(3):619-28. doi: 10.1016/j.celrep.2013.10.011. Epub 2013 Nov 7.

11.

CD44 binds to macrophage mannose receptor on lymphatic endothelium and supports lymphocyte migration via afferent lymphatics.

Salmi M, Karikoski M, Elima K, Rantakari P, Jalkanen S.

Circ Res. 2013 Jun 7;112(12):1577-82. doi: 10.1161/CIRCRESAHA.111.300476. Epub 2013 Apr 19.

PMID:
23603511
12.

Altered purinergic signaling in CD73-deficient mice inhibits tumor progression.

Yegutkin GG, Marttila-Ichihara F, Karikoski M, Niemelä J, Laurila JP, Elima K, Jalkanen S, Salmi M.

Eur J Immunol. 2011 May;41(5):1231-41. doi: 10.1002/eji.201041292.

13.

Different role of CD73 in leukocyte trafficking via blood and lymph vessels.

Ålgars A, Karikoski M, Yegutkin GG, Stoitzner P, Niemelä J, Salmi M, Jalkanen S.

Blood. 2011 Apr 21;117(16):4387-93. doi: 10.1182/blood-2010-11-321646. Epub 2011 Feb 23.

PMID:
21346249
14.

Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activity.

Liaskou E, Karikoski M, Reynolds GM, Lalor PF, Weston CJ, Pullen N, Salmi M, Jalkanen S, Adams DH.

Hepatology. 2011 Feb;53(2):661-72. doi: 10.1002/hep.24085. Epub 2011 Jan 10.

15.

Clever-1/Stabilin-1 regulates lymphocyte migration within lymphatics and leukocyte entrance to sites of inflammation.

Karikoski M, Irjala H, Maksimow M, Miiluniemi M, Granfors K, Hernesniemi S, Elima K, Moldenhauer G, Schledzewski K, Kzhyshkowska J, Goerdt S, Salmi M, Jalkanen S.

Eur J Immunol. 2009 Dec;39(12):3477-87. doi: 10.1002/eji.200939896.

16.

The prototype endothelial marker PAL-E is a leukocyte trafficking molecule.

Keuschnigg J, Henttinen T, Auvinen K, Karikoski M, Salmi M, Jalkanen S.

Blood. 2009 Jul 9;114(2):478-84. doi: 10.1182/blood-2008-11-188763. Epub 2009 May 6.

PMID:
19420356
17.

Inhibition of semicarbazide-sensitive amine oxidases decreases lymphocyte infiltration in the early phases of rat liver allograft rejection.

Martelius T, Salmi M, Krogerus L, Loginov R, Schoultz M, Karikoski M, Miiluniemi M, Soots A, Höckerstedt K, Jalkanen S, Lautenschlager I.

Int J Immunopathol Pharmacol. 2008 Oct-Dec;21(4):911-20.

PMID:
19144276
18.

Macrophage mannose receptor on lymphatics controls cell trafficking.

Marttila-Ichihara F, Turja R, Miiluniemi M, Karikoski M, Maksimow M, Niemelä J, Martinez-Pomares L, Salmi M, Jalkanen S.

Blood. 2008 Jul 1;112(1):64-72. doi: 10.1182/blood-2007-10-118984. Epub 2008 Apr 23.

PMID:
18434610
19.

VAP-1-deficient mice display defects in mucosal immunity and antimicrobial responses: implications for antiadhesive applications.

Koskinen K, Nevalainen S, Karikoski M, Hänninen A, Jalkanen S, Salmi M.

J Immunol. 2007 Nov 1;179(9):6160-8.

20.

The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding.

Jalkanen S, Karikoski M, Mercier N, Koskinen K, Henttinen T, Elima K, Salmivirta K, Salmi M.

Blood. 2007 Sep 15;110(6):1864-70. Epub 2007 Jun 4.

PMID:
17548577

Supplemental Content

Loading ...
Support Center